Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States

Liver Transplantation

Volumn 18, Issue 1, 2012, Pages 29-37

  Afzali, Anita ^a,c   Berry, Kristin ^b   Ioannou, George N ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; FEMALE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NECROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SURVIVAL; UNITED STATES;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FATTY LIVER; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84255162259     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22435     Document Type: Article

References (21)

1. Angulo P,. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395. (Pubitemid 39657013)
3. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ,. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419. (Pubitemid 29258890)
4. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140. (Pubitemid 34747534)
5. Angulo P, Keach JC, Batts KP, Lindor KD,. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362.
6. Burke A, Lucey MR,. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004; 4: 686-693. (Pubitemid 38637564)
7. Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J,. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009; 9: 782-793.
8. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW,. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80. (Pubitemid 20075105)
9. Evans CD, Oien KA, MacSween RN, Mills PR,. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? J Clin Pathol 2002; 55: 689-692. (Pubitemid 34970092)
10. Koehler E, Watt K, Charlton M,. Fatty liver and liver transplantation. Clin Liver Dis 2009; 13: 621-630.
11. Poonawala A, Nair SP, Thuluvath PJ,. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32 (pt 1): 689-692.
12. Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001; 7: 363-373. (Pubitemid 32331542)
13. Vuppalanchi R, Chalasani N,. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009; 49: 306-317.
14. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P,. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-121. (Pubitemid 41002048)
15. Ong JP, Pitts A, Younossi ZM,. Non-alcoholic fatty liver disease (NAFLD) is associated with higher overall mortality and liver related mortality. J Hepatol 2008; 48 (suppl 2): S5.
16. Ioannou GN,. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006; 12: 1594-1606. (Pubitemid 44742538)
17. Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL,. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl 2010; 16: 431-439.
18. Centers for Disease Control and Prevention. Overweight and obesity. Accessed August 2011.
19. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ,. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669. (Pubitemid 29109578)
20. Clark JM, Diehl AM,. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003; 289: 3000-3004. (Pubitemid 37430103)
21. Struben VM, Hespenheide EE, Caldwell SH,. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 2000; 108: 9-13. (Pubitemid 30058272)